Locking Plates for Distal Femur Fractures - a Multicenter Case Review
Launched by AO INNOVATION TRANSLATION CENTER · Jul 3, 2019
Trial Information
Current as of April 25, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is examining how well certain types of plates used in surgery heal distal femur fractures, which are fractures in the thigh bone near the knee. Researchers are looking at images taken of patients who had these fractures and were treated with special plates. They want to understand how often these treatments fail and what factors might contribute to that. The study will review the details of each case, such as the type of fracture, how the surgery was performed, and how well the bone healed over time.
To participate in this study, individuals need to be at least 18 years old and have a specific type of distal femur fracture. This could be from either a low-energy injury, like a fall, or a high-energy injury, like a car accident. Participants should have had surgery using one of the specified plates and must have their x-ray images available for review, showing their injury and healing process. This study is currently active, but it is not enrolling new participants at this time. It aims to gather valuable information that could improve future treatments for these types of fractures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years and older
- • Diagnosis of a distal femur fracture type OTA/AO classification 33-A, -B, -C
- • uni- or bilateral
- • low or high energy trauma
- • Open or closed fractures
- • Surgical treatment with the VA-LCP DF, LISS DF, LCP DF
- • Available radiographical documentation, beginning with the injury radiographs, ending with the documented healing or any documented failure with or without revision surgery (up to a maximum follow-up of 1 year
Trial Officials
Mark Lee, MD
Principal Investigator
University of California Davis, Dept. of Orthopaedic Surgery
About Ao Innovation Translation Center
The AO Innovation Translation Center (AO ITC) is a leading clinical trial sponsor dedicated to advancing orthopedic research and innovation. With a focus on translating cutting-edge scientific discoveries into clinical applications, AO ITC collaborates with healthcare professionals, researchers, and industry partners to facilitate the development of novel therapies and technologies. By leveraging its extensive network and expertise, AO ITC aims to enhance patient care and outcomes in the field of musculoskeletal health, ensuring that innovative solutions are efficiently brought to market and accessible to those in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Liestal, Baselland, Switzerland
Chur, Graubünden, Switzerland
Fairfax, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials